Patent details
EP2819516 Title: USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
Basic Information
- Publication number:
- EP2819516
- PCT Application Number:
- US2012000335
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP128200581
- PCT Publication Number:
- WO2013019271
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
- French Title of Invention:
- UTILISATION DE (1R,5S)-(+)-L-(NAPHTHALÈN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE DANS LE CADRE DU TRAITEMENT D'AFFECTIONS ASSOCIÉES AUX NEUROTRANSMETTEURS MONO-AMINE
- German Title of Invention:
- VERWENDUNG VON (1R,5S)-(+)-1-(NAPHTALEN-2-YL)-3-AZABICYCLO-{3.1.0-}HEXAN BEI DER BEHANDLUNG VON DURCH MONOAMIN-NEUROTRANSMITTER VERMITTELTEN LEIDEN
- SPC Number:
Dates
- Filing date:
- 27/07/2012
- Grant date:
- 25/12/2019
- EP Publication Date:
- 07/01/2015
- PCT Publication Date:
- 07/02/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/12/2019
- EP B1 Publication Date:
- 25/12/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 27/07/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/12/2019
- Name:
- Otsuka America Pharmaceutical, Inc.
- Address:
- 2440 Research Boulevard, Rockville, MD 20850, United States (US)
Agent
- Name:
- VALIPAT
- From:
- 18/03/2020
- Address:
- Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
- To:
Inventor
1
- Name:
- BYMASTER, Frank
- Address:
- United States (US)
2
- Name:
- MCKINNEY, Anthony Alexander
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201161574231 P
- Priority Date:
- 30/07/2011
- Priority Country:
- United States (US)
2
- Priority Number:
- 201113334066
- Priority Date:
- 22/12/2011
- Priority Country:
- United States (US)
3
- Priority Number:
- 201213528940
- Priority Date:
- 21/06/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/00; A61K 31/403; A61P 25/00;
Publication
European Patent Bulletin
- Issue number:
- 201952
- Publication date:
- 25/12/2019
- Description:
- Grant (B1)
Deed
Power of attorney
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC20200000085A
- Date Registered:
- 18/03/2020
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- VALIPAT
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/07/2025
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 11/07/2024
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/03/2020 | Request For Change | 2 |
| 18/03/2020 | Outgoing Correspondence | 1 |